An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism
Crossref DOI link: https://doi.org/10.1186/s12958-017-0232-y
Published Online: 2017-03-07
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nieschlag, Eberhard http://orcid.org/0000-0002-1403-3298
Bouloux, Pierre-Marc G.
Stegmann, Barbara J.
Shankar, R. Ravi
Guan, Yanfen
Tzontcheva, Anjela
McCrary Sisk, Christine
Behre, Hermann M.
Funding for this research was provided by:
Merck